Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick?s disease
Abstract
Abnormal tau hyperphosphorylation and deposition in Pick bodies is a major abnormality in Pick's disease (PiD). This is associated with increased expression of the stress-activated protein kinase, p38 kinase, which has the capacity to phosphorylate tau in vitro. The present study has shown increased expression of phosphorylated p38 (p38-P), which does not cross-react with phospho-tau, in sarcosyl-insoluble fractions enriched in abnormal filaments, and hyperphosphorylated tau in the brain of two PiD cases obtained and processed with very short (less than 2 h) post-mortem delay. Immunohistochemical studies have shown p38-P co-localization in 90% of neurons with Pick bodies, whereas no positive cells are encountered in control brains processed in parallel. Moreover, p38-immunoprecipitated from sarcosyl-insoluble fractions in PiD brains is functionally active as it has the capacity to phosphorylate its specific substrate ATF-2. Combined biochemical, immunohistochemical and functional studies indicate that active p38 kinase is expressed in a very high percentage of Pick bodies, thus suggesting a critical role of this kinase in enhancing and perpetuating tau hyperphosphorylation in PiD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Phospho-p38 is found exclusively in cells with NFT or tau aggregates in AD cases, co-localizes with tau aggregates in tauopathic brains, and co-precipitates with insoluble tau in both human cases and transgenic AD mouse models.
“Phospho-p38 is found exclusively in cells with NFT or tau aggregates in AD cases (152,153), co-localizes with tau aggregates in tauopathic brains (145,154) and co-precipitates with insoluble tau in both human cases and transgenic AD mouse models (145,148).”
From Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation (2011) · cites this paper as [154]
Cites
Oxidative stress in Alzheimer’s disease
Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00040-5 · Cited by 895 · see citing works
Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3107 · Cited by 165 · see citing works
Reactivating Kinase/p38 Phosphorylates τ Protein In Vitro
Reynolds, C. H., Nebreda, A. R., Gibb, G. M., Utton, M. A., & Anderton, B. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010191.x · Cited by 161 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113 · see citing works
“Phospho-p38 is found exclusively in cells with NFT or tau aggregates in AD cases (152,153), co-localizes with tau aggregates in tauopathic brains (145,154) and co-precipitates with insoluble tau in both human cases and transgenic AD mouse models (145,148).”
Background
- Authors
- Puig, B., Vinals, F., & Ferrer, I.
- Affiliations
- Bellvitge University Hospital (ES)
- ORCID
- Puig, Berta
- Venue
- Acta Neuropathologica
- Published
- 2004-03-01
- Volume
- 107
- Issue
- 3
- Pages
- 185-189
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2093385459
- Cited by
- 27
- References
- 3
- Citations by year
- 2020: 2 · 2019: 2 · 2017: 2 · 2014: 2 · 2013: 1
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Pick's disease, p38 MAPK, tau hyperphosphorylation, Pick bodies, tau phosphorylation, c-Jun N-terminal kinase, ATF2 phosphorylation, neurofibrillary tangles, postmortem delay
- MeSH terms
- Animals, Brain, Cell Count, Cell Fractionation, Cell Line, Humans, Immunohistochemistry, Neurons, Phosphorylation, Precipitin Tests, Staining and Labeling, Transcription Factors, Blotting, Western, Case-Control Studies, tau Proteins, Cyclic AMP Response Element-Binding Protein, Pick Disease of the Brain, Mitogen-Activated Protein Kinases, Myoblasts, p38 Mitogen-Activated Protein Kinases, Mice, Activating Transcription Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review